Skylar Jeremias

The study, on the quality of on-demand video telemedicine services, found that patients using telemedicine for respiratory infections were more likely to receive follow-up care, causing higher health care spending.

Given the high prevalence of Kawasaki disease during the pandemic, Japanese investigators determined that droplet or contact transmission of pathogens is likely not a major route causing the development of the disease.

A meta-analysis, where many studies ranged in evidence quality, revealed mixed results on the effectiveness of blended self-management interventions in chronic lung conditions, establishing a need for more research.

Patients with chronic obstructive pulmonary disease (COPD) were found to be more likely to take medications for depression or anxiety than for other common comorbidities associated with the disease, investigators concluded.

Physicians should evaluate female patients complaining of chronic cough for psychological conditions when determining course of treatment as the two may be related, investigators concluded.

A quality assessment program conducted in the Republic of Korea may be effective in improving disease management and prognosis for patients with chronic obstructive pulmonary disease (COPD), but the effects may be temporary.

A review found that a low-carbohydrate diet may lead patients with type 2 diabetes to experience disease remission, potentially providing new insight into how clinicians can help patients better manage their disease, investigators concluded.

Researchers found that physicians may have a financial conflict of interest when examining a chest x-ray for black lung disease, suggesting that sweeping changes are needed to avoid biases and improve transparency.

Two therapeutic regimens used for the treatment of chronic obstructive pulmonary disease (COPD) are rarely being prescribed to patients without a COPD diagnosis, investigators concluded.

Exposure to nitrogen dioxide (NO2), an air pollutant generated from automobiles, may increase risk of mortality, even if the exposure amount is well below regulatory limits, investigators concluded.

Largely driven by hospitalizations and medications, health care costs were found to be 3 times greater for patients with chronic obstructive pulmonary disease (COPD) than for healthy individuals, according to a recent Danish study.

Investigators found 10 main themes characterizing the differences between primary care clinics classified as high- and low-performing in distributing diabetes care.

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life.

A recent study found that a sizable portion of the commercially insured asthma population lacks disease control, regardless of asthma severity, signaling a needed shift in treatment strategies.

Despite patients with pulmonary arterial hypertension reporting good quality of life and low symptom severity, functional limitations persisted, suggesting improvements to the patient experience are needed, according to researchers.

Patients with chronic obstructive pulmonary disease (COPD) with clinically important deterioration were found to have greater exacerbations and mortality risks; however, triplet therapy could help rectify that.

Spinal muscular atrophy treatment Zolgensma was found to be safe and effective for long-term use and use in presymptomatic patients, according to posters presented at the 2021 MDA Virtual Clinical & Scientific Conference.

Patients discharged from hospitals after recovering from severe COVID-19 were found to have lasting functional impairment and post-traumatic stress symptoms months after, according to a study.

After Medicare Part D plans stopped covering a chronic obstructive pulmonary disease (COPD) therapy, patients had gaps in care and increased out-of-pocket costs, according to a recent study.

Results of a survey depicting the ways that spinal muscular atrophy (SMA) affects the lives of adolescents and young adults revealed areas of support that need to be addressed to ensure that patients are able to live their best possible lives.

Researchers analyzed 2 cohorts of patients with chronic obstructive pulmonary disease (COPD) to characterize who is most at risk for developing hypercapnia and who could most benefit from at-home noninvasive inhalation therapy.

Telerehabilitation programs for chronic obstructive pulmonary disease (COPD) have to address uptake barriers surrounding inadequate funding and access issues for elderly patients in order to last in a post–COVID-19 world, according to researchers.

Female patients and those under age 50 have a greater risk of severe asthma exacerbations and a lower health-related quality of life, despite having better lung function compared with male and older patients.

Although 90% of patients with severe asthma choose to continue using a biologic, patients with worse disease control at baseline or with lower socioeconomic status (SES) may be more likely to cease biologic use, according to a poster presented at the American Academy of Allergy, Asthma & Immunology 2021 Annual Meeting.

Despite receiving specialty referrals and multiple prescriptions medications, nearly 40% of patients with an unexplained chronic cough are not given a proper diagnosis.

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids plus bronchodilators.

Researchers found that thousands of patients with chronic obstructive pulmonary disease (COPD) did not follow the traditional trajectory associated with the disease, suggesting a possible incorrect diagnosis.

From 1999 to 2015, permanent disability claims for patients with rheumatoid arthritis (RA) spiked during periods of economic recessions, suggesting that the COVID-19 pandemic may create a similar effect in the near future.

Results from the AIRFLOW-1 study demonstrate that targeted lung denervation did not produce any severe adverse reactions in patients with chronic obstructive pulmonary disease (COPD) after 3 years.

A recent study found that patients immunized against influenza were less likely to test positive for or have serious complication related to coronavirus disease 2019 (COVID-19).